Brazil’s Silent Battle Against Barriga d’Água: Why Schistosomiasis Refuses to Disappear

In the coastal villages of Pernambuco and the peri-urban settlements scattered across Brazil’s Northeast, a parasitic worm that has plagued the country for centuries is quietly rewriting its own epidemiological story. Schistosomiasis mansoni, known locally as “barriga d’água” or “water belly,” has defied decades of drug campaigns, surveillance programs, and public health initiatives to remain entrenched in the world’s largest endemic zone in the Americas. A comprehensive new review published in Frontiers in Tropical Diseases by researchers at the Oswaldo Cruz Institute and Fluminense Federal University reveals a disease at a critical inflection point, one where declining national statistics mask a more troubling reality of concentrated transmission pockets, an aging infected population, and a healthcare system struggling to catch what its old tools can no longer see.

The review, led by Isabelle Soares, Keyla Nunes Farias Gomes, and Robson Xavier Faria, synthesizes fifteen years of epidemiological data, diagnostic protocols, and control strategies spanning 2010 to 2026. Its central finding is paradoxical: while aggregate national prevalence has declined, the disease has become more deeply rooted in specific geographic clusters where sanitation infrastructure remains inadequate. Brazil reported 40,314 confirmed cases through its Notifiable Diseases Information System in 2023, yielding a notification rate of 19.83 per 100,000 inhabitants. Yet this figure, calculated against an estimated population of roughly 203 million, conceals dramatic spatial heterogeneity. In coastal Pernambuco, prevalence in rural and peri-urban communities can reach 80 percent, a level driven by the compounding effects of historical socioenvironmental vulnerability and the parasite’s expansion into zones previously classified as low risk.

What makes this epidemiological transition particularly insidious is the demographic shift it has produced. The disease now concentrates predominantly in adults and older individuals, with a mean age of 40 and a median of 39. This is not simply a reflection of transmission patterns changing; it is substantially confounded by Brazil’s general population aging and a fundamental shift in how cases are detected. As routine active school-based screening has declined across the country, detection has migrated toward passive presentation in primary health units, capturing an aging cohort carrying what the researchers call a cumulative “legacy burden” — individuals infected decades ago who have developed progressive liver fibrosis due to unmanaged chronic exposure. The age distribution pyramid shows a predominant concentration of cases in the 30 to 39 and 40 to 49 age brackets, alongside a significant volume in individuals over 60 years of age.

The clinical consequences of this legacy are severe and molecularly well-characterized. Symmers’ pipe-stem fibrosis, the hallmark of chronic hepatosplenic schistosomiasis, is a systematized periportal process driven by a dysregulated T-helper 2 immune response to parasite eggs trapped in liver tissue. These eggs secrete antigens that trigger the release of profibrotic cytokines, including interleukin-13 and transforming growth factor-beta 1, which activate hepatic stellate cells to deposit excessive collagen in the portal tract. The result is intrahepatic portal flow obstruction, esophageal varices, and a stabilization of residual mortality rates in regions where diagnostic delays prevent early intervention. For these patients, the disease has already done its structural damage, and treatment with antiparasitic drugs cannot reverse established fibrosis.

Complicating the picture further is the parasite’s remarkable biological resilience. Schistosoma mansoni depends on a freshwater gastropod, Biomphalaria glabrata, as its intermediate host, and this mollusk is recognized as the most effective vector precisely because of its high degree of compatibility with the parasite. High-resolution genomic analyses have revealed that B. glabrata possesses a highly complex and plastic genetic architecture, with specific gene clusters that modulate susceptibility or resistance to infection. These variations, particularly within immune-related regions of the snail, allow the vector to sustain the parasite’s intramolluscan larval development across diverse environmental conditions, ensuring a continuous supply of infective cercariae in endemic water bodies. When these larvae contact human skin, they deploy a sophisticated molecular toolkit: a potent cocktail of elastases and proteases that enzymatically dissolve the dermal extracellular matrix, alongside an array of immunomodulators that suppress the host’s innate immune response and effectively cloak the parasite during its critical initial migration into the venous system.

Within Brazil’s Unified Health System, the strategic response to this persistent threat has undergone a significant overhaul. The 2024–2026 strategic plan emphasizes a shift from traditional, low-sensitivity Kato-Katz fecal smears toward high-sensitivity diagnostic technologies capable of identifying low-parasite-load infections and asymptomatic carriers who would otherwise remain untreated and continue fueling transmission. The point-of-care circulating cathodic antigen urine test, or POC-CCA, has emerged as a promising field tool for rapid screening. However, the review is unequivocal about its current status: despite its field utility, POC-CCA is not recommended or formally incorporated by the Brazilian Ministry of Health for routine use in the SUS, owing to unsatisfactory specificity and false-positive results observed in nonendemic Brazilian settings. Molecular assays such as quantitative PCR and ultrasensitive circulating anodic antigen tests remain restricted to research settings and national reference laboratories like Fiocruz, where they are deployed to evaluate persistent cases or low-density transmission foci.

On the therapeutic front, praziquantel remains the exclusive drug of choice following the formal discontinuation of oxamniquine from the national arsenal. The standardized dosing regimen is calibrated to age-specific pharmacokinetics: a single oral dose of 50 milligrams per kilogram for adults, capped at 3 grams, and 60 milligrams per kilogram for children over two years of age weighing more than 10 kilograms. Recent clinical updates have focused on the safety and efficacy of crushed praziquantel tablets for preschool-aged children, ensuring that this vulnerable demographic is adequately covered in mass deworming efforts. For severe acute manifestations such as Katayama fever or neurological involvement, the protocol mandates adjunctive corticosteroids to modulate the intense inflammatory response. In advanced chronic cases, particularly the hepatosplenic form, clinical focus shifts toward managing portal hypertension through endoscopic sclerotherapy or surgical intervention for esophageal varices.

Yet the review’s most pointed argument is that pharmacological intervention alone is fundamentally insufficient for elimination. Mass drug administration with praziquantel reduces immediate morbidity and individual parasite loads, but it cannot prevent reinfection in the absence of structural reform. The 2024–2026 strategic plan therefore emphasizes Integrated Environmental Engineering as a superior long-term investment compared with exclusive reliance on chemotherapy. Initiatives such as paving open drainage ditches, installing snail-proof irrigation systems, and providing universal access to treated water permanently modify the habitat of Biomphalaria snails. Although the initial capital investment is higher, the long-term cost-effectiveness is superior in elimination settings because it prevents reinfection and reduces the chronic disability and lost productivity associated with ongoing transmission. The recent implementation of the Brazilian Legal Framework for Sanitation represents a pivotal shift in this direction, aiming to universalize access to potable water and sewage treatment, thereby directly interrupting the parasite’s life cycle at the miracidium-to-snail interface.

Surveillance technology is also evolving to meet the challenge. Environmental DNA, or eDNA, allows researchers to detect Schistosoma and its snail hosts within aquatic ecosystems even at low densities, providing health authorities with a high-resolution map of active transmission sites that traditional malacological surveys might overlook. This precision malacology represents a vital frontier for early outbreak detection, particularly as chemical control with niclosamide, while still a cornerstone for reducing intermediate host populations, has proven insufficient as a standalone measure. Longitudinal studies indicate that gastropod populations often recover following consecutive treatments, underscoring the need for integrated approaches that combine chemical, environmental, and social interventions. The review also highlights the importance of considering nonhuman definitive hosts, particularly wild rodents such as Nectomys squamipes, which play an active role in maintaining the parasite’s biological cycle in endemic areas.

Achieving the World Health Organization’s 2030 target of eliminating schistosomiasis as a public health problem will require what the authors describe as an unwavering One Health commitment, integrating rigorous clinical follow-up for chronic patients with universal sanitation and proactive malacological surveillance. The transition from a morbidity control paradigm to total transmission interruption demands that pharmacological interventions be inextricably coupled with structural environmental reform. Sustained fiscal investment and political will are essential not only for procuring next-generation diagnostics but also for maintaining a multidisciplinary workforce capable of conducting sophisticated surveillance. Ultimately, the elimination of schistosomiasis in Brazil is not merely a pharmacological challenge; it is a social and environmental imperative. Only through a steadfast commitment to addressing the biological, environmental, and socioeconomic determinants of transmission in a unified manner can Brazil secure a future free from the burden of this neglected tropical disease, and in doing so, break the cycle of poverty and disease that has sustained it for generations.

Subject of Research: Epidemiology, diagnostics, and integrated control strategies for Schistosomiasis mansoni in Brazil

Article Title: Contemporary challenges of Schistosomiasis mansoni in Brazil: a review of epidemiological indicators, SUS protocols, and control strategies (2010–2026)

Article References: Contemporary challenges of Schistosomiasis mansoni in Brazil: a review of epidemiological indicators, SUS protocols, and control strategies (2010–2026). (n.d.). https://doi.org/10.3389/fitd.2026.1918824

Image Credits: AI Generated

DOI: 10.3389/fitd.2026.1918824

Keywords: schistosomiasis, Schistosoma mansoni, Brazil, One Health, praziquantel, Biomphalaria glabrata, public health, neglected tropical diseases, sanitation, diagnostics, SUS, environmental DNA